Publicaciones en colaboración con investigadores/as de Centro de Investigación Médica Aplicada (7)

2022

  1. Messenger RNA as a personalized therapy: The moment of truth for rare metabolic diseases

    International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 55-96

2021

  1. Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma

    Hepatology, Vol. 73, Núm. 6, pp. 2380-2396

  2. Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: Dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis

    Gut, Vol. 70, Núm. 2, pp. 388-400

2020

  1. Pilot multi-omic analysis of human bile from benign and malignant biliary strictures: A machine-learning approach

    Cancers, Vol. 12, Núm. 6, pp. 1-30

2019

  1. Role of AGAP2 in the profibrogenic effects induced by TGFβ in LX-2 hepatic stellate cells

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1866, Núm. 4, pp. 673-685

2007

  1. Reactive oxygen species (ROS) mediate the effects of leucine on translation regulation and type I collagen production in hepatic stellate cells

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1773, Núm. 11, pp. 1681-1688

2006

  1. Differential regulation of the JNK/AP-1 pathway by S-adenosylmethionine and methylthioadenosine in primary rat hepatocytes versus HuH7 hepatoma cells

    American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 290, Núm. 6